RE:Huge uptick potential like
I like the idea of the IP being used with a consistent producer like Jones soda or otherwise. NU showing their lack of experience in manufacturing product (late orders and such) scaling up requires outside help and that is where the IP licensing holds good value. I got into this through lexaria, NU used to work closely with them. Not sure what happened when they broke, but they appear to have similar rapid onset, offset and more measurable dosing between them both. Now, a large producer like that, if I was them, I would probably lean towards lexaria for a cbd drink. Bioavailibility and measurable dosing is a key for them either way and we offer that also. Like Glen mentionned in one of those interviews, it takes only one big b2b connection to make a huge footprint and seems reasonable to think larger producers with recognized names and marketing of their own would take note of that. I think there is room for more than one in this space, and even a few contracts like those would make past financials look like a footnote, like adjusting rouding after not using pennies anymore. I am optimistic about the future potential in many ways that could as previously mentionned become a 5000% in time. This inability to ship orders in timely fashion only makes me doubt their ability to manufacture themselves. (Could be learning pains). It is a great thing that they have alot more options on the table and potential for far more than just what they can make in their facility.